Riskpilot← Back to searchSign inGet full accessEmbark Holdings ApS
APSActiveCVR 44152223Ottiliavej 9Activities of holding companies · NACE 6421Est. 20232 employees
Revenue 2025
DKK 18,6M
+16% vs 2024
EBITDA margin
81.8%
+23% vs 2024
Equity ratio
92.8%
Financial strength
Net profit 2025
DKK 5,7M
+262% vs 2024
| Revenue | DKK 18,6M | +16% |
| EBITDA | DKK 15,2M | +23% |
| Net profit | DKK 5,7M | +262% |
| Total assets | DKK 37M | +13% |
| Equity | DKK 34,4M | +20% |
| Employees | 2 | — |
Legal name
Embark Holdings ApS
CVR number
44152223
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
29. juni 2023
Share capital
DKK 320.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at foretage investeringer i aktiver, herunder immaterielle, og aktiviteter relaterede til forskning og udvikling rettet mod fremstilling og kommercialisering af protein-baserede lægemidler og andre med generel lægemiddeludvikling relaterede aktiviteter, samt at yde konsulentydelser til selskaber, som er beskæftigede indenfor selskabets hovedformål, herunder datterselskaber af Selskabet.
Address
Ottiliavej 9
Email
cth@embarkbiotech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 17.912 | 16.030 | 18.575 |
| Staff expenses | -9.550 | -3.639 | -3.381 |
| EBITDA | 8.363 | 12.391 | 15.194 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | 8.363 | 12.391 | 15.194 |
| Net financials | 45.668 | -16.065 | -9.538 |
| Profit before tax | 54.031 | -3.674 | 5.656 |
| Tax | -0 | -139 | -63 |
| Net profit | 54.031 | -3.535 | 5.719 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 113.826 | 32.792 | 37.027 |
| Equity | 94.056 | 28.646 | 34.365 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 19.770 | 4.146 | 2.662 |
| Total debt | 19.770 | 4.146 | 2.662 |
EBITDA margin
81.8%
This company
15.8%
Market median
+418% vs market
20232025
Equity ratio
92.8%
This company
38.2%
Market median
+143% vs market
20232025
Return on equity
16.6%
This company
18.4%
Market median
+10% vs market
20232025
Net profit margin
30.8%
This company
8.1%
Market median
+280% vs market
20232025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20232025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20232025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2023-06-29 – 2023-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CT Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gerhart-Hines Holding ApS | Company | 20.0% | 20.0% | 2024 |
Bondo Hansen Holding ApS | Company | 20.0% | 20.0% | 2024 |
Receptor Holding ApS | Company | 20.0% | 20.0% | 2024 |
CTH Holding Invest ApS | Company | 10.0% | 10.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CTH Holding Invest ApS
Embark Holdings ApS Board members of Embark Holdings ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Casper Tind Hansen | Chief Executive Officer | 0 companies |
| Klaus Christian Schollmeier | Chairman | 0 companies |